FDA Inspection
LGM Pharma Solutions, LLCLGM Pharma Solutions, LLC – FDA Inspection, Apr 2, 2010
Record Details
This FDA Inspection record concerns LGM Pharma Solutions, LLC, with an inspection on April 2, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- LGM Pharma Solutions, LLC
- Inspection Date
- April 2, 2010
- Product Type
- Drugs
View Company Profile
ID · c947ca2d-5abb-41ca-8ec9-1ef3a47176b5
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 657733
- FDA center
- Human Drugs
- Project area
- Unapproved and Misbranded Drugs
Other FDA inspections of LGM Pharma Solutions, LLC
13| Date | Classification | Office | Project area |
|---|---|---|---|
| May 18, 2026 | Not classified | Los Angeles District Office | Drug Quality Assurance |
| January 24, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 1, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 31, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 17, 2018 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
Other documents for LGM Pharma Solutions, LLC
- FDA Inspection 1317740 - 2026-05-18
- FDA Inspection 1232056 - 2025-01-24
- FDA Inspection 1230374 - 2024-03-01
- FDA Inspection 1120565 - 2020-01-31
- FDA Inspection 1062404 - 2018-08-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.